Kistler-Tiffany Companies’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $455K | Buy |
8,110
+843
| +12% | +$47.3K | 0.07% | 208 |
|
|
2023
Q1 | $329K | Buy |
7,267
+3,050
| +72% | +$138K | 0.06% | 235 |
|
|
2022
Q4 | $171K | Buy |
4,217
+3,435
| +439% | +$140K | 0.04% | 290 |
|
|
2022
Q3 | $51K | Buy |
782
+266
| +52% | +$17.3K | 0.01% | 376 |
|
|
2022
Q2 | $31K | Sell |
516
-70
| -12% | -$4.21K | 0.01% | 437 |
|
|
2022
Q1 | $37K | Buy |
586
+205
| +54% | +$12.9K | 0.01% | 428 |
|
|
2021
Q4 | $29K | Buy |
381
+375
| +6,250% | +$28.5K | 0.01% | 441 |
|
|
2021
Q3 | $1K | Hold |
6
| – | – | ﹤0.01% | 692 |
|
|
2021
Q2 | $1K | Buy |
6
+2
| +50% | +$333 | ﹤0.01% | 682 |
|
|
2021
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 673 |
|
|
2020
Q4 | $1K | Buy |
+4
| New | +$1K | ﹤0.01% | 611 |
|